Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses
P. Aukrust et al., Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses, EUR J CL IN, 30(3), 2000, pp. 252-259
Citations number
39
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background Vitamin A has a broad range of immunological effects, and vitami
n A deficiency is associated with recurrent: infections. Common variable im
munodeficiency (CVI) is a group of B-cell deficiency syndromes with impaire
d antibody production and recurrent bacterial infections as the major manif
estations, but the immunological dysfunctions may also include T cells and
macrophages. In the present study pre examined the possible role of vitamin
A deficiency in CVI.
Patients and methods We analysed plasma vitamin A levels in 20 CVI patients
and 16 controls, and examined the relationships between vitamin A and clin
ical, immunological and metabolic parameters in CVI. In the six CVI patient
s with the lowest vitamin A levels we also studied the effect of vitamin A
supplementation in vivo an several immunological functions in these patient
s.
Results (i) The majority of CVI patients had decreased vitamin A levels com
pared with healthy controls, as found in both cross-sectional and longitudi
nal testing. (ii) Low vitamin A levels were associated with the occurrence
of chronic bacterial infections and splenomegaly as well as high neopterin
levels. Decreased levels of carrier protein and malabsorption were not obse
rved, (iii) Vitamin A supplementation in patients with lour vitamin A level
s resulted in increased interleukin-10 (IL-10) and decreased tumour necrosi
s factar-alpha (TNF alpha) levels, as found in both plasma and monocyte sup
ernatants, possibly favouring anti-inflammatory net effects. (iv) Vitamin A
supplementation in vivo also enhanced anti-CD40-stimulated IgG production,
serum IgA levels and phytohaemagglutinin (PHA)-stimulated peripheral blood
mononuclear cell (PBMC) proliferation.
Conclusion A considerable subgroup of CVI patients appears to be characteri
zed by low vitamin A levels. Our findings support a possible role for vitam
in A supplementation in CVI, perhaps resulting in enhanced immunoglobulin s
ynthesis and downregulated inflammatory responses.